Related Experiment Video

Updated: Jul 20, 2026

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
12:03

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

Epidermal growth factor receptor-targeted molecular therapeutics for head and neck squamous cell carcinoma

Ann Marie Egloff, Jennifer Grandis

    Expert Opinion on Therapeutic Targets
    |September 20, 2006
    PubMed

    Insights

    Molecular-targeted therapies, including epidermal growth factor receptor (EGFR) inhibitors, show promise for head and neck squamous cell carcinoma (HNSCC). However, reliable molecular markers to predict patient response to EGFR therapy are still needed.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Translational Research

    Background:

    • Head and neck squamous cell carcinoma (HNSCC) treatment is exploring molecular-targeted therapeutics.
    • Epidermal growth factor receptor (EGFR) targeted agents have shown clinical effectiveness in HNSCC trials.
    • Identifying predictive molecular signatures for EGFR-targeted therapy in HNSCC remains a challenge.

    Discussion:

    • This review summarizes clinical findings for EGFR-targeted therapeutics in HNSCC.
    • It highlights molecular correlative studies investigating biomarkers for treatment response.
    • Data from other cancer types targeting EGFR are included for broader relevance.

    Key Insights:

    • Despite clinical efficacy, no definitive molecular markers predict response to EGFR inhibitors in HNSCC.
    • Current research focuses on identifying specific molecular signatures for patient stratification.
    • Understanding molecular alterations is crucial for optimizing EGFR-targeted treatment strategies.

    Outlook:

    • Further research is needed to validate potential molecular markers for EGFR-targeted therapy in HNSCC.
    • Translational studies integrating molecular data with clinical outcomes are essential.
    • This review aims to guide future research and clinical practice in HNSCC treatment.

    More Related Videos

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

    Published on: April 22, 2019

    Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

    Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

    Published on: April 20, 2018

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    Transducer Mechanism: Enzyme-Linked Receptors01:27

    Transducer Mechanism: Enzyme-Linked Receptors

    Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
    Major types that are helpful drug targets include: